The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19

NCT04629157 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

This is a Pilot Study Which Aims to Assess the Validity and Applicability of Lateral Flow Assays (LFAs) Which Can be Used as a Point of Care Test for COVID-19
Covid19

Interventions

DEVICE: Innova Lateral Flow Device

Sponsor

Alder Hey Children's NHS Foundation Trust